ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 97 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $345,000 | – | 23,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $35,188,000 | 48.80% |
| VR Adviser, LLC | 4,563,962 | $82,151,000 | 10.55% |
| COMMODORE CAPITAL LP | 2,190,291 | $39,425,000 | 10.39% |
| Foresite Capital Management IV, LLC | 3,399,034 | $61,183,000 | 9.01% |
| Foresite Capital Management V, LLC | 1,258,243 | $22,648,000 | 7.04% |
| Parkman Healthcare Partners LLC | 1,306,460 | $23,516,000 | 5.95% |
| Asymmetry Capital Management, L.P. | 241,701 | $4,351,000 | 2.62% |
| Jetstream Capital LLC | 140,000 | $2,520,000 | 2.44% |
| Aisling Capital Management LP | 634,455 | $11,420,000 | 2.28% |
| Samsara BioCapital, LLC | 794,171 | $14,295,000 | 2.24% |